We have located links that may give you full text access.
Cardiovascular biomarker troponin I biosensor: Aptamer-Gold-Antibody Hybrid on a metal oxide surface.
Biotechnology and Applied Biochemistry 2022 June 29
Myocardial infarction (MI) is highly related to the cardiac arrest leading to death and damage of the organs. Radiological techniques and electrocardiography have been used as the preliminary tests to diagnose MI; however, these techniques are not sensitive enough for the early-stage detection. A blood biomarker-based diagnosis is the immediate solution, and due to the high correlation of troponin with MI, it has been considered to be a gold-standard biomarker. In the present research, cardiac biomarker troponin I (cTnI) was detected on an interdigitated electrode sensor with varied surface interfaces. To detect cTnI, a capture aptamer-conjugated gold nanoparticle probe and detection antibody probe were utilized and compared through an alternating the sandwich pattern. The surface metal oxide morphology of the developed sensor was proved by microscopic assessments. The limit of detection with the aptamer-gold-cTnI-antibody sandwich pattern was 100 aM, while it was 1 fM with antibody-gold-cTnI-aptamer, representing 10-folds differences. Further, high performance of the sensor was confirmed by selective cTnI determination in serum, exhibiting a superior nonfouling. These methods of determination provide options for generating novel assays for diagnosing MI. This article is protected by copyright. All rights reserved.
Full text links
Related Resources
Trending Papers
Renin-Angiotensin-Aldosterone System: From History to Practice of a Secular Topic.International Journal of Molecular Sciences 2024 April 5
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities.Diabetologia 2024 April 17
British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease.Rheumatology 2024 April 17
Albumin: a comprehensive review and practical guideline for clinical use.European Journal of Clinical Pharmacology 2024 April 13
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app